Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 15/20 | 0.64 |
| ▸ | MAOA | P21397 | 11/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6205706 | 0.92 | MAOB (0.61) | MAOBMAOAHRH3 | |
| SCHEMBL6190278 | 0.88 | MAOB (0.72) | MAOBMAOAHRH3CASP1CASP7 | |
| SCHEMBL15839932 | 0.79 | MAOB (0.68) | MAOBMAOA | |
| SCHEMBL16539590 | 0.78 | MAOB (1.00) | MAOBMAOAHRH3 | |
| SCHEMBL29090878 | 0.76 | MAOB (0.60) | MAOBMAOAHRH3CASP1CASP7 | |
| SCHEMBL1915443 | 0.76 | MAOB (0.60) | MAOBMAOAHRH3CASP1CASP7 | |
| SCHEMBL1239457 | 0.76 | MAOB (0.60) | MAOBMAOAHRH3CASP1CASP7 | |
| SCHEMBL13256053 | 0.76 | MAOB (0.56) | MAOBMAOAHRH3CASP1CASP7 | |
| SCHEMBL6231954 | 0.75 | THRA (0.38) | MAOBMAOA | |
| SCHEMBL5638876 | 0.75 | MAOB (0.86) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1157015-B1 | USE OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF LIPOMETABOLIC DISORDERS, OBESITAS AND TYP II DIABETES | AVENTIS PHARMA GMBH (DE) | 2005-05-11 | — | — | EP | disclosed |
| EP-1173176-B1 | UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY | AVENTIS PHARMA GMBH (DE) | 2004-05-26 | — | — | EP | disclosed |
| US-6476059-B1 | Use of polycyclic 2-aminothiazole systems for the treatment of obesity | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-11-05 | — | — | US | disclosed |
| EP-1173176-A1 | UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY | Aventis Pharma Deutschland GmbH (DE) | 2002-01-23 | — | — | EP | disclosed |
| EP-1157015-A1 | POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS | Aventis Pharma Deutschland GmbH (DE) | 2001-11-28 | — | — | EP | disclosed |
| US-6251922-B1 | TREATMENT OF OBESITY AND DIABETES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-06-26 | — | — | US | disclosed |
| WO-2000051602-A1 | UTILIZATION OF POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS IN THE PRODUCTION OF MEDICAMENTS FOR PROPHYLAXIS OR TREATMENT OF OBESITY | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000051995-A1 | POLYCYCLIC 2-AMINO-THIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENT CONTAINING SAID COMPOUNDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |